These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5716119)

  • 1. [Effects of intensified chemotherapeutic regimens in the re-treatment of pulmonary tuberculosis].
    Maekawa N
    Kekkaku; 1968 Dec; 43(12):523-5. PubMed ID: 5716119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the re-treatment of pulmonary tuberculosis with special reference to the factors needed to be known for selecting adequate chemotherapeutic regimens].
    Kameda K
    Kekkaku; 1968 Dec; 43(12):513-5. PubMed ID: 5716114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on the chemotherapeutic regimens in re-treatment of cavitary tuberculosis with sputum positive for tubercle bacilli].
    Yamamoto M
    Kekkaku; 1968 Dec; 43(12):517-9. PubMed ID: 5716116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined use of capreomycin and ethambutol in the re-treatment of pulmonary tuberculosis].
    Donomae I
    Saishin Igaku; 1968 Nov; 23(11):2393-9. PubMed ID: 5715168
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium on comparison of clinical efficacy among various kinds of chemotherapeutic regimens for pulmonary tuberculosis. 2. Results of studies by the Cooperative Study Unit on Chemotherapy of Tuberculosis in the national sanatorium].
    Shimamura K
    Kekkaku; 1966 Sep; 41(9):436-42. PubMed ID: 5975805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of pulmonary tuberculosis].
    Citron KM
    Recenti Prog Med; 1970 Jul; 49(1):98-108. PubMed ID: 5536441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Re-treatment of refractory pulmonary tuberculosis].
    Ogata H
    Kekkaku; 1992 Oct; 67(10):674-6. PubMed ID: 1453570
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern treatment of tuberculosis].
    Gulsvik A
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):867-9. PubMed ID: 3590128
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of the toxic effects of antibacterial drugs during intravenous injections to patients with tuberculosis].
    Ivaniuta OM
    Vrach Delo; 1971; (2):55-7. PubMed ID: 5099050
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the re-treatment of relapsed cases of pulmonary tuberculosis].
    Yamamoto M
    Kekkaku; 1968 Dec; 43(12):515-7. PubMed ID: 5716115
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of single and divided daily dosage of chemotherapeutics in the treatment of pulmonary tuberculosis].
    Baba H; Azuma Y
    Kekkaku; 1972 Jul; 47(7):221-6. PubMed ID: 5081210
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choice and methods of applications of chemotherapeutic agents in the therapy of pulmonary tuberculosis].
    Lucchesi M
    G Ital Mal Torace; 1971; 25(1):15-25. PubMed ID: 5131784
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis].
    Iizuka Y; Iwasaki T; Fujioka K
    Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of short-course chemotherapy in pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Apr; 5(2):78-81. PubMed ID: 7128354
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the re-treatment of pulmonary tuberculosis with special reference to the major factors which affect the results of re-treatment].
    Kayaba K
    Kekkaku; 1968 Dec; 43(12):511-2. PubMed ID: 5716113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
    Celotti A
    Minerva Med; 1965 Sep; 56(71):2892-7. PubMed ID: 5322270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical trial of a 3-month regimen and 2 5-month regimens in the treatment of pulmonary tuberculosis. 2d study of the short-term treatment administered in Madras].
    Tripathy SP
    Bull Int Union Tuberc; 1983 Jun; 58(2):97-101. PubMed ID: 6360263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.